Bibliography
1. Briasoulis A, Inampudi C, Akintoye E, et al. Regional Variation in
Mortality, Major Complications, and Cost After Left Ventricular Assist
Device Implantation in the United States (2009 to 2014). Am J
Cardiol . 2018;121(12):1575-1580. doi:10.1016/j.amjcard.2018.02.047
2. Shah N, Agarwal V, Patel N, et al. National Trends in Utilization,
Mortality, Complications, and Cost of Care after Left Ventricular Assist
Device Implantation from 2005 to 2011. Ann Thorac Surg .
2016;101(4):1477-1484. doi:10.1016/j.athoracsur.2015.09.013
3. Mehra MR, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Left
Ventricular Assist Device — Final Report. N Engl J Med .
Published online 2019:NEJMoa1900486. doi:10.1056/NEJMoa1900486
4. Dang NC, Topkara VK, Mercando M, et al. Right heart failure after
left ventricular assist device implantation in patients with chronic
congestive heart failure. J Heart Lung Transplant .
2006;25(1):1-6. doi:10.1016/j.healun.2005.07.008
5. Briasoulis A, Akintoye E, Mohsen A, et al. Trends in utilization,
mortality, major complications, and cost after total artificial heart
implantation in the United States (2009-2015). Hell J Cardiol .
2019;(xxxx). doi:10.1016/j.hjc.2019.02.002
6. Levin AP, Jaramillo N, Garan AR, et al. Outcomes of contemporary
mechanical circulatory support device configurations in patients with
severe biventricular failure. J Thorac Cardiovasc Surg .
2016;151(2):530-535.e2. doi:10.1016/j.jtcvs.2015.10.019
7. Arabía FA, Cantor RS, Koehl DA, et al. Interagency registry for
mechanically assisted circulatory support report on the total artificial
heart. J Hear Lung Transplant . 2018;37(11):1304-1312.
doi:10.1016/j.healun.2018.04.004
8. Kiernan MS, Wilson Grandin E, Brinkley M, et al. Early Right
Ventricular Assist Device Use in Patients Undergoing Continuous-Flow
Left Ventricular Assist Device Implantation: Incidence and Risk Factors
from the Interagency Registry for Mechanically Assisted Circulatory
Support. Circ Hear Fail . 2017;10(10).
doi:10.1161/CIRCHEARTFAILURE.117.003863
9. Soliman OII, Akin S, Muslem R, et al. Derivation and validation of a
novel right-sided heart failure model after implantation of continuous
flow left ventricular assist devices. Circulation .
2018;137(9):891-906. doi:10.1161/CIRCULATIONAHA.117.030543
10. Fitzpatrick JR, Frederick JR, Hiesinger W, et al. Early planned
institution of biventricular mechanical circulatory support results in
improved outcomes compared with delayed conversion of a left ventricular
assist device to a biventricular assist device. J Thorac
Cardiovasc Surg . 2009;137(4):971-977. doi:10.1016/j.jtcvs.2008.09.021
11. Shah P, Ha R, Singh R, et al. Multicenter experience with durable
biventricular assist devices. J Hear Lung Transplant .
2018;37(9):1093-1101. doi:10.1016/j.healun.2018.05.001
12. Converse MP, Sobhanian M, Taber DJ, Houston BA, Meadows HB, Uber WE.
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in
Patients With Left Ventricular Assist Devices. J Am Coll Cardiol .
2019;73(14):1769-1778. doi:10.1016/j.jacc.2019.01.051
13. Ghashghaei R, Yousefzai R, Liwinski F, Tran H, Adler ED. The Role of
Neurohormonal Therapy in Patients with Left Ventricular Assist Devices.J Hear Lung Transplant . 2016;35(4):S396.
doi:10.1016/j.healun.2016.01.1143